CONCLUSION
The drugs which are used to cure runny noses and watery eyes throughout
the allergy season may also treat tumour progression in cancer.
Anti-histamines contain certain anti-cancer properties that hinder a
type of cell which decreases the body’s potential to fight the malignant
tumour. Many cancers such as colorectal cancer, breast cancer, prostate
cancer, ovarian cancer and melanoma found aggressively high levels of
histamine receptors. The findings of particular studies estimated on
cancer cell growth besides the impact of mast cell mediators recommended
that in future cancer therapeutics, mast cells could be a positive
target because as inhibition of these mediators prevents cancer growth,
inhibition of pro-inflammatory mediators by degranulation of mast cell.
In cancer therapy, Compared to chemotherapeutic agent antihistamines are
a lot safer and have low toxicity. It is redeemed to learn the promising
effect of the most common over-the-counter medication anti-histamine.
The researchers are thrilled to know more about the connection between
inflammation and cancer. However, more investigation is needed to
determine whether anti-histamine can be used effectively in cancer
treatment. Although it’s not the time to use anti-histamine in cancer
prevention, still need to read and research more suppressor cells as
their product can become immunotherapy targets for cancer. It is
important to shed light on the precise concentration of histamine
receptors in different areas as well as the kinds of tumors and their
activation in certain tumor growth by estimating them in vitro and in
vivo studies before recommending anti-histamine as a new cancer
medication to cancer patients. Recent studies suggest that researchers
should be open-minded about examining the immune process or mechanism
superficially.